Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Vaccine. 2020 Apr 11;38(22):3854–3861. doi: 10.1016/j.vaccine.2020.03.044

Table 2.

Attitudes towards Ebola vaccine and Ebola risk perception among respondents# in a national household survey, Sierra Leone, December 2014.

# Item& N % 95% CI
1 Please say if you agree, disagree, or have no opinion about the following statement. “A vaccine to protect against Ebola is needed to help fight Ebola in Sierra Leone.”
Agree 3217 92.5 90.6–94.0
Somewhat agree 143 4.1 3.0–5.6
Disagree 119 3.4 2.6–4.5
2 If a vaccine that has been tested to be safe in humans and could protect against Ebola becomes available in Sierra Leone, how likely would you be to take it?
Very likely to take it 2701 77.9 74.1–81.3
Somewhat likely to take it 590 17.0 14.3–20.1
Not very likely to take it 114 3.3 2.5–4.3
Not at all likely to take it 62 1.8 1.2–2.6
3 If a vaccine that has been tested to be safe in humans and could protect against Ebola becomes available in Sierra Leone, how likely would your family be to take it?
Very likely to take it 2653 77.2 73.3–80.7
Somewhat likely to take it 595 17.3 14.6–20.4
Not very likely to take it 129 3.8 2.9–4.9
Not at all likely to take it 58 1.7 1.2–2.5
4 If a vaccine that has been tested to be safe in humans and could protect against Ebola becomes available in Sierra Leone, who do you think should take it first?
Me or my family 869 25.5 22.2–29.0
Healthcare workers or burial teams 1262 36.9 40.0–40.9
Political leaders 471 13.8 11.8–16.0
Pregnant women 41 1.2 0.7–2.1
Children 98 2.9 2.0–4.1
Team that is offering the Ebola vaccine to others 336 9.8 8.0–12.0
People who live in worst affected areas 281 8.2 6.6–10.2
Other 57 1.7 1.0–2.7

CI = confidence interval.

#

N = 3540 respondents.

&

Don’t know and declined responses excluded: 61 missing for item-1; 73 missing for item-2; 105 missing for item-3; 125 missing for item-4.